ADPT- Adaptive Biotechnologies Corporation

Name: Adaptive Biotechnologies Corporation Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Adaptive Biotechnologies Corporation (ADPT) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. ADPT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Robins Chad M	2.18M	$32.03M	-
Other	Robins Harlan S	1.51M	$22.21M	-
Other	Bobulsky Susan	427.8K	$6.28M	-
COO	Rubinstein Julie	396.8K	$5.83M	-259,638
Other	Benzeno Sharon	272.8K	$4.01M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 27, 2026	Rubinstein Julie88	President And COO	Sale+OE	19,037	$14.23	$270,896.51	-4.8%	-	-
Apr 24, 2026	Rubinstein Julie88	President And COO	Sale+OE	57,180	$13.96	$798,423.40	-4.7%	-	-
Apr 21, 2026	Rubinstein Julie88	President And COO	Sale+OE	69,061	$14.60	$1,008,622.26	-5.4%	-	-
Apr 16, 2026	Rubinstein Julie88	President And COO	Sale+OE	57,180	$14.45	$826,251.00	-4.4%	-	-
Apr 13, 2026	Rubinstein Julie88	President And COO	Sale+OE	57,180	$13.26	$758,108.34	-2.2%	-	-
Apr 8, 2026	Robins Harlan S85	Chief Scientific Officer	Sell	10,000	$14.85	$148,500.00	-0.7%	-	-
Apr 8, 2026	Lo Francis80	Chief People Officer	Sale+OE	22,564	$15.07	$340,039.48	-7.7%	-	-
Apr 8, 2026	Robins Chad M63	CEO And Chairman	Sell	120,595	$14.65	$1,766,839.09	-2.7%	-	-
Apr 8, 2026	Rubinstein Julie88	President And COO	Sale+OE	69,061	$14.34	$990,503.43	-3.8%	-	-
Apr 2, 2026	Rubinstein Julie88	President And COO	Sale+OE	38,120	$14.53	$553,693.00	-4.1%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC